Voluntary HIV Screening in the General Population in France (depistageVIH)

February 17, 2026 updated by: Université de Reims Champagne-Ardenne

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed.

Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Objectives

The main objective is to describe the voluntary HIV screening methods used by the general population in France.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Subjects aged 18 years or older, whether or not they have previously undergone voluntary HIV testing, residing in France, and agreeing to participate in the study.

Description

Inclusion Criteria:

  • 18 years of age or older
  • Male or female
  • Regardless of sexual orientation
  • Whether or not they have previously undergone voluntary HIV testing
  • Agreeing to participate in the study.

Exclusion Criteria:

  • Minors
  • Refusing to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The method(s) used for undergoing voluntary HIV testing questionnaire
Time Frame: Day 0
The method(s) used for undergoing voluntary HIV testing: medical prescription, Center for Free Information, Testing, and Diagnosis, medical laboratory, rapid diagnostic test (RDT), or self-test
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2025

Primary Completion (Estimated)

April 7, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

February 11, 2026

First Submitted That Met QC Criteria

February 17, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025_RIPH_08_DEPISTAGEVIH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Human Immunodeficiency Virus (HIV)

Clinical Trials on data collections

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe